These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29480046)

  • 1. [Review of the relation between gut microbiome, metabolic disease and hypertension].
    Barna I; Nyúl D; Szentes T; Schwab R
    Orv Hetil; 2018 Mar; 159(9):346-351. PubMed ID: 29480046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes.
    Johnson EL; Heaver SL; Walters WA; Ley RE
    J Mol Med (Berl); 2017 Jan; 95(1):1-8. PubMed ID: 27900395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
    Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
    Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The human gut microbiota: Interactions with the host and dysfunctions].
    Lepage P
    Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Host-microbiota crosstalk and cardiovascular diseases].
    Amar J
    Presse Med; 2018 Sep; 47(9):775-779. PubMed ID: 29909161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity.
    Denou E; Marcinko K; Surette MG; Steinberg GR; Schertzer JD
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E982-93. PubMed ID: 27117007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota and metabolic diseases.
    Pascale A; Marchesi N; Marelli C; Coppola A; Luzi L; Govoni S; Giustina A; Gazzaruso C
    Endocrine; 2018 Sep; 61(3):357-371. PubMed ID: 29721802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery.
    Guo Y; Huang ZP; Liu CQ; Qi L; Sheng Y; Zou DJ
    Eur J Endocrinol; 2018 Jan; 178(1):43-56. PubMed ID: 28916564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenobiotics: Interaction with the Intestinal Microflora.
    Lu K; Mahbub R; Fox JG
    ILAR J; 2015; 56(2):218-27. PubMed ID: 26323631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
    Schiattarella GG; Sannino A; Esposito G; Perrino C
    Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle alters GUT-bacteria function: Linking immune response and host.
    Jazayeri O; Daghighi SM; Rezaee F
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):625-635. PubMed ID: 29566905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases.
    Brial F; Le Lay A; Dumas ME; Gauguier D
    Cell Mol Life Sci; 2018 Nov; 75(21):3977-3990. PubMed ID: 30101405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Core Gut Microbiome of the American Cockroach, Periplaneta americana, Is Stable and Resilient to Dietary Shifts.
    Tinker KA; Ottesen EA
    Appl Environ Microbiol; 2016 Nov; 82(22):6603-6610. PubMed ID: 27590811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the normal gut microbiota.
    Jandhyala SM; Talukdar R; Subramanyam C; Vuyyuru H; Sasikala M; Nageshwar Reddy D
    World J Gastroenterol; 2015 Aug; 21(29):8787-803. PubMed ID: 26269668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crosstalk between gut microbiota and obesity and related metabolic disorders.
    Xu WT; Nie YZ; Yang Z; Lu NH
    Future Microbiol; 2016 Jun; 11():825-36. PubMed ID: 27192213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
    Brahe LK; Astrup A; Larsen LH
    Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.
    Ussar S; Fujisaka S; Kahn CR
    Mol Metab; 2016 Sep; 5(9):795-803. PubMed ID: 27617202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.